Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000200359 | SCV000250832 | benign | not specified | 2014-08-26 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV000769554 | SCV000319458 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2015-02-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Illumina Laboratory Services, |
RCV000358235 | SCV000354236 | benign | Loeys-Dietz syndrome 4 | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Labcorp Genetics |
RCV000358235 | SCV000559140 | benign | Loeys-Dietz syndrome 4 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000590091 | SCV000698187 | benign | not provided | 2017-07-14 | criteria provided, single submitter | clinical testing | Variant summary: The TGFB2 c.114G>A (p.Glu38Glu) variant involves the alteration of a conserved nucleotide, resulting in a synonymous change. Mutation taster predicts a damaging outcome for this variant. 5/5 splice prediction tools predict no significant impact on normal splicing. ESE finder predicts that this variant may affect binding of multiple ESE sites. However, these predictions have yet to be confirmed by functional studies. This variant was found in 405/121312 control chromosomes (3 homozygotes) from ExAC, predominantly observed in the South Asian subpopulation at a frequency of 0.013931 (230/16510). This frequency is about 1114 times the estimated maximal expected allele frequency of a pathogenic TGFB2 variant (0.0000125), suggesting this is likely a benign polymorphism found primarily in the populations of South Asian origin. In addition, multiple clinical diagnostic laboratories (via ClinVar) have classified this variant as benign/likely benign. Taken together, this variant is classified as benign. |
Center for Human Genetics, |
RCV000660310 | SCV000782349 | likely benign | Connective tissue disorder | 2016-11-01 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000358235 | SCV000884680 | benign | Loeys-Dietz syndrome 4 | 2023-04-17 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000769554 | SCV000900950 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2016-03-30 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002277541 | SCV002566111 | benign | Ehlers-Danlos syndrome | 2022-05-30 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000358235 | SCV002807984 | benign | Loeys-Dietz syndrome 4 | 2021-10-27 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000590091 | SCV004125636 | benign | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | TGFB2: BP4, BS1, BS2 |
Breakthrough Genomics, |
RCV000590091 | SCV005263728 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Genome Diagnostics Laboratory, |
RCV000200359 | SCV001809397 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000200359 | SCV001932935 | benign | not specified | no assertion criteria provided | clinical testing |